University of Minnesota. Driven to Discover.
Officials hope the promising treatment findings encourage more patients to seek lifesaving treatment.
Immune response lasted 2.5 years for the vaccines, the longest yet in ongoing studies of Ebola immunization.
The announcement comes as Nigeria is experiencing its largest outbreak, with 481 confirmed cases reported as of last week, 133 of them fatal.
A trial at the end of Liberia's Ebola outbreak shows 2 candidate vaccines posed no major safety concerns and triggered immune responses that lasted at least a year.
Funding will be used to continue trials of BCX4430 and prepare for its large-scale manufacture.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.